Moran Kevin Patrick

Moran Kevin Patrick is listed in filings as SVP at Vanda Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including sale activity and purchase activity. Recent filings connect the profile to Vanda Pharmaceuticals Inc. (VNDA). The current snapshot covers public activity from Jul 29, 2024 to Mar 4, 2026. Reported amounts are shown as $350.8K to $8.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.